HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Botulinum toxin for cricopharyngeal dysphagia: case reports of CT-guided injection.

AbstractOBJECTIVE:
The National Institutes of Health have recognized the use of botulinum toxin (Botox) as a therapeutic agent to treat many ophthalmologic and otolaryngologic disorders. There are three reports in the literature regarding the use of Botox to treat cricopharyngeal dysphagia, all describing good results. In the larger study, the toxin was administered under general anaesthetic. This article discusses CT-guided injection of Botox: a relatively noninvasive, out-patient procedure. We also discuss failure of injection in one case and complications in another.
CONCLUSION:
The patients described experienced improvement in their dysphagia symptoms following injection.
AuthorsS I Atkinson, J Rees
JournalThe Journal of otolaryngology (J Otolaryngol) Vol. 26 Issue 4 Pg. 273-6 (Aug 1997) ISSN: 0381-6605 [Print] CANADA
PMID9263899 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Dyskinesia Agents
  • Botulinum Toxins
Topics
  • Aged
  • Anti-Dyskinesia Agents (therapeutic use)
  • Botulinum Toxins (therapeutic use)
  • Cricoid Cartilage (radiography)
  • Deglutition Disorders (drug therapy, physiopathology)
  • Female
  • Humans
  • Laryngeal Diseases (physiopathology)
  • Male
  • Pharyngeal Diseases (physiopathology)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: